Skip to content

ASX 200 reporting season

How is Cochlear leveraging new technologies to drive growth?

With Cochlear's innovation in technologies, Baby Bunting's ambitious expansion plans, and Amcor's strategic acquisitions, these companies are at the forefront of driving market trends and investor interest.

Video poster image

(AI video summary)

This video was created on 15 August for IG audiences by ausbiz.

Key financial results 

Cochlear (ASX:COH)

Cochlear's full-year sales increased 4% to $2.35 billion, driven by cochlear and acoustic implants, though services revenue declined. Despite a slight drop in gross margins and a 5% reduction in operating expenses, underlying profit rose 1% and net profit climbed 9% to $389 million. Shareholders will receive a final dividend of $2.15 per share.

Baby Bunting (ASX:BBN)

Baby Bunting reported record full-year sales, with profit rising 28% to $12.2 million. The retailer will enhance stores with 10 to 12 'store of the future' refurbishments and open five large-format and three to five small-format stores in financial year (FY) 2026. Early in the new financial year, sales increased 4.8%, driven by growth in New Zealand. The company expects a pro forma net profit of $17 million to $20 million for FY 2026, and shares rose nearly 25%.

Amcor (ASX:AMC)

Amcor's net sales hit US$5 billion in the fourth quarter (Q4), a 43% increase, following the Berry Global acquisition. This is expected to add US$650 million by 2028. Despite a 12% drop in New York-listed shares, Amcor - a steady defensive stock - presents a potential buying opportunity due to robust fundamentals.

Important to know

This information has been prepared by IG, a trading name of IG Australia Pty Ltd. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients.

   

Ready to open an IG account?

Start your trading journey now